These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 21890751)

  • 1. Viremia copy-years predicts mortality among treatment-naive HIV-infected patients initiating antiretroviral therapy.
    Mugavero MJ; Napravnik S; Cole SR; Eron JJ; Lau B; Crane HM; Kitahata MM; Willig JH; Moore RD; Deeks SG; Saag MS;
    Clin Infect Dis; 2011 Nov; 53(9):927-35. PubMed ID: 21890751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early retention in HIV care and viral load suppression: implications for a test and treat approach to HIV prevention.
    Mugavero MJ; Amico KR; Westfall AO; Crane HM; Zinski A; Willig JH; Dombrowski JC; Norton WE; Raper JL; Kitahata MM; Saag MS
    J Acquir Immune Defic Syndr; 2012 Jan; 59(1):86-93. PubMed ID: 21937921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viremia copy-years as a predictive marker of all-cause mortality in HIV-1-infected patients initiating a protease inhibitor-containing antiretroviral treatment.
    Chirouze C; Journot V; Le Moing V; Raffi F; Piroth L; Reigadas S; Cassuto JP; Chêne G; Leport C; Hoen B;
    J Acquir Immune Defic Syndr; 2015 Feb; 68(2):204-8. PubMed ID: 25590273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus viremia in Thai HIV-infected patients on antiretroviral therapy: prevalence and associated mortality.
    Durier N; Ananworanich J; Apornpong T; Ubolyam S; Kerr SJ; Mahanontharit A; Ferradini L; Ruxrungtham K; Avihingsanon A
    Clin Infect Dis; 2013 Jul; 57(1):147-55. PubMed ID: 23511301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cumulative HIV Viremia Copy-Years and Hypertension in People Living with HIV.
    Xu Y; Chen X; Wijayabahu A; Zhou Z; Yu B; Spencer EC; Cook RL
    Curr HIV Res; 2020; 18(3):143-153. PubMed ID: 32003696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with mortality among persistently viraemic triple-antiretroviral-class-experienced patients receiving antiretroviral therapy in the HIV Outpatient Study (HOPS).
    Palella FJ; Armon C; Buchacz K; Chmiel JS; Novak RM; D'Aquila RT; Brooks JT;
    J Antimicrob Chemother; 2014 Oct; 69(10):2826-34. PubMed ID: 24942257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of early HIV viremia with mortality after HIV-associated lymphoma.
    Gopal S; Patel MR; Yanik EL; Cole SR; Achenbach CJ; Napravnik S; Burkholder GA; Reid EG; Rodriguez B; Deeks SG; Mayer KH; Moore RD; Kitahata MM; Richards KL; Eron JJ
    AIDS; 2013 Sep; 27(15):2365-73. PubMed ID: 23736149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent Low-level Viremia While on Antiretroviral Therapy Is an Independent Risk Factor for Virologic Failure.
    Joya C; Won SH; Schofield C; Lalani T; Maves RC; Kronmann K; Deiss R; Okulicz J; Agan BK; Ganesan A
    Clin Infect Dis; 2019 Nov; 69(12):2145-2152. PubMed ID: 30785191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV viremia and incidence of non-Hodgkin lymphoma in patients successfully treated with antiretroviral therapy.
    Achenbach CJ; Buchanan AL; Cole SR; Hou L; Mugavero MJ; Crane HM; Moore RD; Haubrich RH; Gopal S; Eron JJ; Hunt PW; Rodriguez B; Mayer K; Saag MS; Kitahata MM;
    Clin Infect Dis; 2014 Jun; 58(11):1599-606. PubMed ID: 24523217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viremia copy-years and mortality among combination antiretroviral therapy-initiating HIV-positive individuals: how much viral load history is enough?
    Wang R; Haberlen SA; Palella FJ; Mugavero MJ; Margolick JB; Macatangay BJC; Martínez-Maza O; Jacobson LP; Abraham AG
    AIDS; 2018 Nov; 32(17):2547-2556. PubMed ID: 30379686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Risk of Viremia, Immunosuppression, Serious Clinical Events, and Mortality With Increasing Age in Perinatally Human Immunodeficiency Virus-Infected Youth.
    Neilan AM; Karalius B; Patel K; Van Dyke RB; Abzug MJ; Agwu AL; Williams PL; Purswani M; Kacanek D; Oleske JM; Burchett SK; Wiznia A; Chernoff M; Seage GR; Ciaranello AL;
    JAMA Pediatr; 2017 May; 171(5):450-460. PubMed ID: 28346597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy.
    Hunt PW; Cao HL; Muzoora C; Ssewanyana I; Bennett J; Emenyonu N; Kembabazi A; Neilands TB; Bangsberg DR; Deeks SG; Martin JN
    AIDS; 2011 Nov; 25(17):2123-31. PubMed ID: 21881481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cumulative HIV viremia during highly active antiretroviral therapy is a strong predictor of AIDS-related lymphoma.
    Zoufaly A; Stellbrink HJ; Heiden MA; Kollan C; Hoffmann C; van Lunzen J; Hamouda O;
    J Infect Dis; 2009 Jul; 200(1):79-87. PubMed ID: 19476437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus viremia, mortality, and end-organ disease among patients with AIDS receiving potent antiretroviral therapies.
    Wohl DA; Zeng D; Stewart P; Glomb N; Alcorn T; Jones S; Handy J; Fiscus S; Weinberg A; Gowda D; van der Horst C
    J Acquir Immune Defic Syndr; 2005 Apr; 38(5):538-44. PubMed ID: 15793363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cumulative Human Immunodeficiency Viremia, Antiretroviral Therapy, and Incident Myocardial Infarction.
    Delaney JA; Nance RM; Whitney BM; Crane HM; Williams-Nguyen J; Feinstein MJ; Kaplan RC; Hanna DB; Budoff MJ; Drozd DR; Burkholder G; Mugavero MJ; Mathews WC; Moore RD; Eron JJ; Hunt PW; Geng E; Saag MS; Kitahata MM; Heckbert SR
    Epidemiology; 2019 Jan; 30(1):69-74. PubMed ID: 30273188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between HIV viremia during antiretroviral therapy and cardiovascular disease.
    Elvstam O; Marrone G; Engström G; Nilsson PM; Carlander C; Treutiger CJ; Gisslén M; Björkman P
    AIDS; 2022 Nov; 36(13):1829-1834. PubMed ID: 35730359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copy-years viremia as a measure of cumulative human immunodeficiency virus viral burden.
    Cole SR; Napravnik S; Mugavero MJ; Lau B; Eron JJ; Saag MS
    Am J Epidemiol; 2010 Jan; 171(2):198-205. PubMed ID: 20007202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Pregnancy on Response to Antiretroviral Therapy in HIV-Infected African Women.
    Kourtis AP; Wiener J; King CC; Heffron R; Mugo NR; Nanda K; Pyra M; Donnell D; Celum C; Lingappa JR; Baeten JM;
    J Acquir Immune Defic Syndr; 2017 Jan; 74(1):38-43. PubMed ID: 27787340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of persistent low-level viremia among HIV patients on antiretroviral therapy: A prospective cohort study.
    Ding H; Xu J; Liu J; Wang Q; Kang J; Li X; Zhang Z; Han X; Jiang Y; Geng W; Shang H
    HIV Med; 2022 Mar; 23 Suppl 1():64-71. PubMed ID: 35293103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incomplete Recovery of CD4 Cell Count, CD4 Percentage, and CD4/CD8 Ratio in Patients With Human Immunodeficiency Virus Infection and Suppressed Viremia During Long-term Antiretroviral Therapy.
    Mutoh Y; Nishijima T; Inaba Y; Tanaka N; Kikuchi Y; Gatanaga H; Oka S
    Clin Infect Dis; 2018 Aug; 67(6):927-933. PubMed ID: 29509894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.